Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 52 entries
View as:

Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT00162136 Org: User:
Start: 09/30/05 End: 07/31/08 Due: 07/31/09

Phase 1 Trial of Oral Ixabepilone

Phase: N/A Priority: Normal
NCT ID: NCT00632424 Org: User:
Start: 05/31/08 End: 06/30/09 Due: 06/30/10

A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03832426 Org: User:
Start: 11/08/13 End: 10/24/14 Due: 10/24/15

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b

Phase: N/A Priority: Normal
NCT ID: NCT03485846 Org: User:
Start: 11/27/17 End: 11/21/18 Due: 11/21/19

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

Phase: N/A Priority: Normal
NCT ID: NCT04686773 Org: User:
Start: 03/05/21 End: 03/18/22 Due: 03/18/23

Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection

Phase: N/A Priority: Normal
NCT ID: NCT05196477 Org: User:
Start: 07/14/21 End: 08/29/22 Due: 08/29/23

Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06320353 Org: User:
Start: 09/27/23 End: 01/31/26 Due: 01/31/27

Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia

Phase: N/A Priority: Normal
NCT ID: NCT03669484 Org: User:
Start: 08/22/17 End: 05/24/18 Due: 05/24/19

A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00568022 Org: User:
Start: 02/29/08 End: 01/31/10 Due: 01/31/11

Phase I Combination w/ Epirubicin

Phase: N/A Priority: Normal
NCT ID: NCT00322374 Org: User:
Start: 08/31/06 End: 02/28/09 Due: 02/28/10

A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs

Phase: N/A Priority: Normal
NCT ID: NCT03537404 Org: User:
Start: 04/24/17 End: 06/30/17 Due: 06/30/18

Efficacy and Safety Evaluation of Refralon®, Concentrate for Solution for Intravenous Injection in Patients With Paroxysmal and Persistent Atrial Fibrillation and Flutter

Phase: N/A Priority: Normal
NCT ID: NCT05773170 Org: User:
Start: 11/11/22 End: 06/01/23 Due: 06/01/24

Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00207129 Org: User:
Start: 10/31/04 End: 12/31/05 Due: 12/31/06

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Phase: N/A Priority: Normal
NCT ID: NCT01019577 Org: User:
Start: 10/31/05 End: 07/31/07 Due: 07/31/08

Phase I Combination Ixabepilone + Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT00832117 Org: User:
Start: 05/31/09 End: 01/31/11 Due: 01/31/12

Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.

Phase: N/A Priority: Normal
NCT ID: NCT03575702 Org: User:
Start: 07/18/16 End: 09/01/17 Due: 09/01/18

Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00983801 Org: User:
Start: 11/30/09 End: 06/30/11 Due: 06/30/12

Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT00080262 Org: User:
Start: 02/29/04 End: 12/31/06 Due: 12/31/07

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00207090 Org: User:
Start: 09/30/05 End: 11/30/08 Due: 11/30/09

A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00422097 Org: User:
Start: 01/31/07 End: 04/30/11 Due: 04/30/12

BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00049244 Org: User:
Start: 09/30/02 End: - Due: -

Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00683904 Org: User:
Start: 06/30/08 End: 09/30/09 Due: 09/30/10

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00080301 Org: User:
Start: 09/30/03 End: 03/31/08 Due: 03/31/09

A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00370552 Org: User:
Start: 03/31/07 End: 11/30/09 Due: 11/30/10

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

Phase: N/A Priority: Normal
NCT ID: NCT04452474 Org: User:
Start: 06/30/20 End: 01/29/21 Due: 01/29/22